Electra Therapeutics, Inc. ETRA
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -24.46M | -24.46M | -12.68M | ||
| Total Depreciation and Amortization | 61.00K | 61.00K | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 1.17M | 1.17M | 616.00K | ||
| Change in Net Operating Assets | 3.78M | 3.78M | -279.50K | ||
| Cash from Operations | -19.44M | -19.44M | -12.34M | ||
| Capital Expenditure | -13.50K | -13.50K | -58.00K | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 11.40M | 11.40M | 498.50K | ||
| Cash from Investing | 11.39M | 11.39M | 440.50K | ||
| Total Debt Issued | -- | -- | 20.00M | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | 25.00M | 25.00M | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -193.50K | -193.50K | -- | ||
| Cash from Financing | 24.80M | 24.80M | 20.00M | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 16.75M | 16.75M | 8.10M | ||